NYSE - Delayed Quote USD

Alto Neuroscience, Inc. (ANRO)

2.5700
+0.1900
+(7.98%)
At close: June 6 at 4:00:02 PM EDT
2.5800
+0.01
+(0.39%)
After hours: June 6 at 7:55:43 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
210
Operating Expense
69,900
68,610
37,809
27,455
9,292
Operating Income
-69,900
-68,610
-37,809
-27,455
-9,082
Net Non Operating Interest Income Expense
7,493
7,476
979
114
2
Other Income Expense
-776
-297
525
-369
-107
Pretax Income
-63,183
-61,431
-36,305
-27,710
-9,187
Net Income Common Stockholders
-63,183
-61,431
-36,305
-27,710
-9,187
Diluted NI Available to Com Stockholders
-63,183
-61,431
-36,305
-27,710
-9,187
Basic EPS
-2.30
-2.50
-1.42
-2.13
-0.94
Diluted EPS
-2.30
-2.50
-1.42
-2.13
-0.94
Basic Average Shares
26,964.2500
24,602
25,574.3600
12,980
9,731
Diluted Average Shares
27,072.1290
24,602
25,574.3600
12,980
9,731
Total Operating Income as Reported
-69,900
-68,610
-37,809
-29,192
-12,056
Total Expenses
69,900
68,610
37,809
27,455
9,292
Net Income from Continuing & Discontinued Operation
-63,183
-61,431
-36,305
-27,710
-9,187
Normalized Income
-62,502
-61,431
-36,305
-27,341
-9,080
Interest Income
9,120
8,851
2,349
114
2
Interest Expense
1,627
1,375
1,370
0
--
Net Interest Income
7,493
7,476
979
114
2
EBIT
-61,556
-60,056
-34,935
-27,710
-9,082
EBITDA
-60,980
-59,554
-34,562
-27,368
-8,937
Reconciled Depreciation
576
502
373
342
145
Net Income from Continuing Operation Net Minority Interest
-63,183
-61,431
-36,305
-27,710
-9,187
Total Unusual Items Excluding Goodwill
-681
--
525
-369
-107
Total Unusual Items
-681
--
525
-369
-107
Normalized EBITDA
-60,299
-59,554
-34,562
-26,999
-8,830
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/2/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TIL Instil Bio, Inc.
32.89
+8.44%
 
KAPA Kairos Pharma, Ltd.
0.4730
-5.87%
 
TELO Telomir Pharmaceuticals, Inc.
2.1500
+6.97%
 
ESLA Estrella Immunopharma, Inc.
1.0651
+0.48%
 
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
 
ATHA Athira Pharma, Inc.
0.3600
+5.51%
 
KPRX Kiora Pharmaceuticals, Inc.
3.0800
-0.32%
 
XLO Xilio Therapeutics, Inc.
0.7000
+3.20%
 
REVB Revelation Biosciences, Inc.
0.8594
+5.45%
 
KYTX Kyverna Therapeutics, Inc.
3.3900
+15.31%